Biodexa Pharmaceuticals PLC Holding(s) in Company (8356V)
11 Abril 2023 - 7:41AM
UK Regulatory
TIDMBDRX TIDM0QYU
RNS Number : 8356V
Biodexa Pharmaceuticals PLC
11 April 2023
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BNGF1L75
Issuer Name
BIODEXA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An event changing the breakdown of voting rights; Other
Comments
Exercise of Instruments
3. Details of person subject to the notification obligation
Name
Morgan Stanley
City of registered office (if applicable)
Country of registered office (if applicable)
US
Name City of registered office Country of registered office
Morgan Stanley Wilmington, Delaware USA
=========================== ==============================
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s)
subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
04-Apr-2023
6. Date on which Issuer notified
06-Apr-2023
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 0.354664 4.858149 5.212813 1812840
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 0.750228 4.285821 5.036049
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BNGF1L75 123340 0.354664
====================== ====================== ====================== ======================
Sub Total 8.A 123340 0.354664%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Right of recall over
securities lending
agreements at any time at any time 1689500 4.858149
================ ========================== ======================== ==================
Sub Total 8.B1 1689500 4.858149%
======================== ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
Morgan Stanley
(Chain 1)
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley
(Chain 1) Capital Management,
LLC
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley
(Chain 1) Domestic Holdings,
Inc.
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley & Co.
(Chain 1) LLC
======================= ====================== ===================== =====================
Morgan Stanley
(Chain 2)
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley
(Chain 2) International
Holdings Inc.
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley
(Chain 2) International
Limited
======================= ====================== ===================== =====================
Morgan Stanley Morgan Stanley
(Chain 2) Investments (UK)
======================= ====================== ===================== =====================
Morgan Stanley
(Chain 2) Morgan Stanley & Co. International plc 3.204739 3.204739%
=============================================== ===================== =====================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Of the total voting rights attached to shares in Section 8A,
123,340 (0.354664%) of these are the result of stock borrowing
agreements
12. Date of Completion
06-Apr-2023
13. Place Of Completion
Glasgow
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLBFLFFXZLXBBK
(END) Dow Jones Newswires
April 11, 2023 06:41 ET (10:41 GMT)
Biodexa Pharmaceuticals (LSE:BDRX)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Biodexa Pharmaceuticals (LSE:BDRX)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
